title: Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients.
abstract: Vanadium, abbreviated V, is an early transition metal that readily forms coordination complexes with a variety of biological products such as proteins, metabolites, membranes and other structures. The formation of coordination complexes stabilizes metal ions, which in turn impacts the biodistribution of the metal. To understand the biodistribution of V, V in oxidation state iv in the form of vanadyl sulfate (25, 50, 100 mg V daily) was given orally for 6 weeks to 16 persons with type 2 diabetes. Elemental V was determined using Graphite Furnas Atomic Absorption Spectrometry against known concentrations of V in serum, blood or urine. Peak serum V levels were 15.4 ± 6.5, 81.7 ± 40 and 319 ± 268 ng ml(-1) respectively, and mean peak serum V was positively correlated with dose administered (r = 0.992, p = 0.079), although large inter-individual variability was found. Total serum V concentration distribution fit a one compartment open model with a first order rate constant for excretion with mean half times of 4.7 ± 1.6 days and 4.6 ± 2.5 days for the 50 and 100 mg V dose groups respectively. At steady state, 24 hour urinary V output was 0.18 ± 0.24 and 0.97 ± 0.84 mg in the 50 and 100 mg V groups respectively, consistent with absorption of 1 percent or less of the administered dose. Peak V in blood and serum were positively correlated (r = 0.971, p < 0.0005). The serum to blood V ratio for the patients receiving 100 mg V was 1.7 ± 0.45. Regression analysis showed that glycohemoglobin was a negative predictor of the natural log(ln) peak serum V (R(2) = 0.40, p = 0.009) and a positive predictor of the euglycemic-hyperinsulinemic clamp results at high insulin values (R(2) = 0.39, p = 0.010). Insulin sensitivity measured by euglycemic-hyperinsulinemic clamp was not significantly correlated with ln peak serum V. Globulin and glycohemoglobin levels taken together were negative predictors of fasting blood glucose (R(2) = 0.49, p = 0.013). Although V accumulation in serum was dose-dependent, no correlation between total serum V concentration and the insulin-like response was found in this first attempt to correlate anti-diabetic activity with total serum V. This study suggests that V pools other than total serum V are likely related to the insulin-like effect of this metal. These results, obtained in diabetic patients, document the need for consideration of the coordination chemistry of metabolites and proteins with vanadium in anti-diabetic vanadium complexes.
authors: School of Medicine and Biomedical Sciences, University at Buffalo (State University of New York, SUNY), Buffalo, NY 14214, USA. gwillsky@buffalo.edu.
authors: Gail R
authors: GR
authors: Willsky
authors: Katherine
authors: K
authors: Halvorsen
authors: Michael E
authors: ME
authors: Godzala
authors: Lai-Har
authors: LH
authors: Chi
authors: Mathew J
authors: MJ
authors: Most
authors: Peter
authors: P
authors: Kaszynski
authors: Debbie C
authors: DC
authors: Crans
authors: Allison B
authors: AB
authors: Goldfine
authors: Paul J
authors: PJ
authors: Kostyniak
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy / Q000652:urine; D005260:Female; D005916:Globulins; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use* / Q000652:urine; D008297:Male; D008875:Middle Aged; D012044:Regression Analysis; D017968:Vanadium Compounds / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D001786:Blood Glucose; D005916:Globulins; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D017968:Vanadium Compounds; C034028:vanadyl sulfate
references: J Appl Toxicol. 1984 Aug;4(4):206-10
references: 6092450
references: Scand J Work Environ Health. 1979 Sep;5(3):188-94
references: 20120566
references: J Am Chem Soc. 2006 Apr 5;128(13):4437-45
references: 16569021
references: J Appl Physiol (1985). 1998 Feb;84(2):569-75
references: 9475867
references: Inorg Chem. 2005 Jul 25;44(15):5416-27
references: 16022540
references: Physiol Genomics. 2006 Aug 16;26(3):192-201
references: 16684804
references: Antioxid Redox Signal. 2011 Aug 15;15(4):1085-127
references: 21275772
references: J Biol Inorg Chem. 2002 Apr;7(4-5):384-96
references: 11941496
references: Dalton Trans. 2011 Nov 28;40(44):11675-86
references: 21750828
references: J Inorg Biochem. 2012 Mar;108:96-104
references: 22005446
references: Chem Soc Rev. 2008 Nov;37(11):2383-92
references: 18949111
references: Biometals. 2009 Dec;22(6):895-905
references: 19404749
references: J Biol Inorg Chem. 2003 Jan;8(1-2):66-74
references: 12459900
references: J Clin Endocrinol Metab. 1995 Nov;80(11):3311-20
references: 7593444
references: Mass Spectrom Rev. 2006 Mar-Apr;25(2):255-89
references: 16273552
references: Metabolism. 2000 Mar;49(3):400-10
references: 10726921
references: Analyst. 2005 Apr;130(4):442-65
references: 15776152
references: J Clin Invest. 1995 Jun;95(6):2501-9
references: 7769096
references: Dalton Trans. 2009 Apr 7;(13):2428-37
references: 19290378
references: J Inorg Biochem. 2001 May;85(1):33-42
references: 11377693
references: Dalton Trans. 2004 Sep 21;(18):2873-82
references: 15349160
references: J Inorg Biochem. 1984 Feb;20(2):157-69
references: 6609223
references: Curr Med Chem. 2010;17(31):3632-42
references: 20846114
references: Inorg Chem. 1996 May 22;35(11):3388-3393
references: 11666543
references: J Biol Chem. 1984 Nov 10;259(21):13273-81
references: 6386812
references: Can J Physiol Pharmacol. 1995 Jan;73(1):55-64
references: 7600453
references: J Biol Inorg Chem. 2010 Aug;15(6):825-39
references: 20339887
references: J Inorg Biochem. 2009 Apr;103(4):554-8
references: 19162329
references: Chem Soc Rev. 2009 Apr;38(4):1119-38
references: 19421584
references: Bioinorg Chem. 1978 Jun;8(6):503-15
references: 698276
references: J Inorg Biochem. 1999 Nov-Dec;77(3-4):215-24
references: 10643660
references: Am J Physiol. 1986 Aug;251(2 Pt 2):R325-32
references: 3740315
references: J Inorg Biochem. 2000 May 30;80(1-2):65-73
references: 10885465
references: J Inorg Biochem. 2012 Oct;115:44-9
references: 22922310
references: Am J Clin Nutr. 1963 Jan;12:49-53
references: 14027941
references: Dalton Trans. 2012 Jun 28;41(24):7304-18
references: 22576640
references: Metallomics. 2012 Jan;4(1):33-6
references: 22094980
references: J Nutr. 1967 Jun;92(2):245-52
references: 6029075
references: J Biol Inorg Chem. 2011 Aug;16(6):961-72
references: 21667212
references: Clin Pharmacol Ther. 1985 Apr;37(4):431-8
references: 2983924
references: J Inorg Biochem. 2012 Oct;115:87-99
references: 22926028
references: Chem Rev. 1999 Sep 8;99(9):2499-510
references: 11749488
references: J Biol Inorg Chem. 2007 Nov;12(8):1275-87
references: 17805585
references: Scand J Work Environ Health. 1979 Dec;5(4):362-7
references: 538427
references: J Inorg Biochem. 2009 Apr;103(4):643-7
references: 19056126
references: J Inorg Biochem. 2000 Jan 30;78(2):97-108
references: 10766332
references: Int Arch Occup Environ Health. 1981;48(3):251-6
references: 6972918
references: Inorg Chem. 2010 Jan 4;49(1):174-87
references: 19947643
references: Science. 1999 Apr 30;284(5415):805-8
references: 10221913
references: Inorg Chem. 2013 Nov 4;52(21):12262-75
references: 24041403
references: J Inorg Biochem. 2009 Apr;103(4):648-55
references: 19201482
references: Am J Clin Nutr. 1978 Mar;31(3):527-31
references: 629221
references: Clin Chem. 1982 Jan;28(1):79-82
references: 7055940
references: Dalton Trans. 2012 Jun 7;41(21):6419-30
references: 22569684
references: J Am Chem Soc. 2005 Apr 13;127(14):5104-15
references: 15810845
references: Curr Med Chem. 2010;17(31):3701-38
references: 20846109
references: Nature. 1965 Sep 18;207(5003):1301-2
references: 5884654
references: Coord Chem Rev. 2011 Oct;255(19-20):2258-2269
references: 23049138
references: Toxicology. 2000 Jun 8;147(2):89-99
references: 10874156
references: Chem Rev. 2004 Feb;104(2):849-902
references: 14871144
references: Anticancer Agents Med Chem. 2011 Jan;11(1):164-71
references: 21269257
references: Biochemistry. 1975 Oct 21;14(21):4573-7
references: 241383
references: J Inorg Biochem. 2009 Apr;103(4):585-9
references: 19203797
references: Metabolism. 1996 Sep;45(9):1130-5
references: 8781301
references: Br J Pharmacol. 1999 Jan;126(2):467-77
references: 10077240
references: Dalton Trans. 2004 Feb 7;(3):421-8
references: 15252549
references: J Clin Endocrinol Metab. 2001 Mar;86(3):1410-7
references: 11238540
references: J Inorg Biochem. 2006 Dec;100(12):1925-35
references: 17055061
references: Inorg Chem. 2011 Apr 18;50(8):3717-28
references: 21434616